Provider knowledge of contrast-induced acute kidney injury

American Journal of the Medical Sciences

Volumn 338, Issue 4, 2009, Pages 280-286

  Jasuja, Deepak ^a   Mor, Maria K ^b,d   Hartwig, Kathryn C ^b   Palevsky, Paul M ^c   Fine, Michael J ^b,c   Weisbord, Steven D ^b,c  

^a USA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Acute kidney injury; Contrast; Knowledge; Providers

Indexed keywords

ACETYLCYSTEINE; AMINOPHYLLINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BICARBONATE; CALCIUM CHANNEL BLOCKING AGENT; DOPAMINE; FENOLDOPAM; GLUCOSE; IODINATED CONTRAST MEDIUM; LOOP DIURETIC AGENT; MANNITOL; SODIUM CHLORIDE; THEOPHYLLINE; WATER;

ACUTE KIDNEY FAILURE; ANEMIA; ARTICLE; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; CONTRAST ENHANCEMENT; CONTRAST INDUCED NEPHROPATHY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG HYPERSENSITIVITY; HEALTH CARE PERSONNEL; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; IATROGENIC DISEASE; KIDNEY INJURY; LOW DRUG DOSE; PERIPHERAL VASCULAR DISEASE; RADIOLOGIST; RISK FACTOR;

EID: 70350182005     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181a87e21     Document Type: Article

References (27)

1. Hou SH, Bushinsky DA, Wish JB, et al. Hospital-acquired renal insufficiency: a prospective study. Am J Med 1983;74:243-248
2. Lameier NH. Contrast-induced nephropathy-prevention and risk reduction. Nephrol Dial Transplant 2006;21:i11-23.
3. McCullough PA, Wolyn R, Rocher LL, et al. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997;103:368-375
4. Mueller C, Buerkle G, Buettner HJ, et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002;162:329-336
5. Rudnick MR, Goldfarb S, Wexler L, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int 1995;47:254-261
6. Solomon R, Werner C, Mann D, et al. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994;331:1416-1420
7. Solomon RJ, Natarajan MK, Doucet S, et al. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease. Circulation 2007;115:3189-3196
8. Weisbord SD, Mor MK, Resnick AL, et al. Prevention, incidence, and outcomes of contrast-induced acute kidney injury. Arch Intern Med 2008;168:1325-1332
9. Barrett BJ, Parfrey PS, Vavasour HM, et al. Contrast nephropathy in patients with impaired renal function: high versus low osmolar media. Kidney Int 1992;41:1274-1279
10. Solomon R. Radiocontrast-induced nephropathy. Semin Nephrol 1998; 18:551-557
11. Taliercio CP, Vlietstra RE, Fisher LD, et al. Risks for renal dysfunction with cardiac angiography. Ann Intern Med 1986;104: 501-504
12. Weisberg LS, Kurnik PB, Kurnik BR. Radiocontrast-induced nephropathy in humans: role of renal vasoconstriction. Kidney Int 1992; 41:1408-1415
13. Aspelin P, Aubry P, Fransson SG, et al. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003;348: 491-499
14. Barrett BJ, Carlisle EJ. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media. Radiology 1993; 188:171-178
15. McCullough PA, Stacul F, Becker CR, et al. Contrast-Induced Nephropathy (CIN) Consensus Working Panel: executive summary. Rev Cardiovasc Med 2006;7:177-197
16. Rudnick M, Tumlin J. Prevention of radiocontrast media-induced acute kidney injury. Rose BD, editor. Up to date. Waltham (MA): UptoDate; 2007.
17. ESUR Guidelines on Contrast Media. Available at: www.esur.org. Accessed February 1, 2007.
18. Konen E, Konen O, Katz M, et al. Are referring clinicians aware of patients at risk from intravenous injection of iodinated contrast media? Clin Radiol 2002;57:132-135
19. Reddan D, Fishman EK. Radiologists' knowledge and perceptions of the impact of contrast-induced nephropathy and its risk factors when performing computed tomography examinations: a survey of European radiologists. Eur J Radiol 2008;66:235-245
20. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol 2004;44:1393-1399
21. Rudnick MR, Berns JS, Cohen RM, et al. Contrast media-associated nephrotoxicity. Curr Opin Nephrol Hypertens 1996;5:127-133
22. Weisberg LS, Kurnik PB, Kurnik BR. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int 1994; 45:259-265
23. Merten GJ, Burgess WP, Gray LV, et al. Prevention of contrastinduced nephropathy with sodium bicarbonate: a randomized controlled trial. JAMA 2004;291:2328-2334
24. Stone GW, McCullough PA, Tumlin JA, et al. Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA 2003;290:2284-2291
25. Weisberg LS, Kurnik PB, Kurnik BR. Dopamine and renal blood flow in radiocontrast-induced nephropathy in humans. Ren Fail 1993; 15:61-68
26. Abizaid AS, Clark CE, Mintz GS, et al. Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency. Am J Cardiol 1999;83:260 -3, A265.
27. Weisbord SD, Chen H, Stone RA, et al. Associations of increases in serum creatinine with mortality and length of hospital stay after coronary angiography. J Am Soc Nephrol 2006;17:2871-2877